How to buy Avid Bioservices stock | 8.04

Avid Bioservices, Inc is a biotechnology business based in the US. Avid Bioservices shares (CDMO) are listed on the NASDAQ and all prices are listed in US Dollars. Avid Bioservices employs 222 staff and has a trailing 12-month revenue of around USD$69.8 million.

How to buy shares in Avid Bioservices

1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
3. Search for Avid Bioservices. Find the stock by name or ticker symbol: CDMO. Research its history to confirm it's a solid investment against your financial goals.
4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Avid Bioservices reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
5. Decide on how many to buy. At last close price of USD$8.04, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Avid Bioservices, depending on your broker.
6. Check in on your investment. Congratulations, you own a part of Avid Bioservices. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

How has coronavirus impacted Avid Bioservices's share price?

Since the stock market crash in March caused by coronavirus, Avid Bioservices's share price has had significant positive movement.

Its last market close was USD$8.04, which is 10.70% up on its pre-crash value of USD$7.18 and 166.23% up on the lowest point reached during the March crash when the shares fell as low as USD$3.02.

If you had bought USD$1,000 worth of Avid Bioservices shares at the start of February 2020, those shares would have been worth USD$566.35 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth USD$1,240.73.

Avid Bioservices share price

Use our graph to track the performance of CDMO stocks over time.

Avid Bioservices shares at a glance

• Key figures

Information last updated 2020-10-20.

Latest market close	USD$8.04
52-week range	USD$3.02 - USD$9.1
50-day moving average	USD$7.69
200-day moving average	USD$6.7346
Wall St. target price	USD$11
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	USD$-0.18

Buy Avid Bioservices shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

Is it a good time to buy Avid Bioservices stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Avid Bioservices, Inc by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Avid Bioservices price performance over time

Historical closes compared with the close of $8.04 from 2020-10-19

1 week (2020-11-19)	-9.66%
1 month (2020-10-26)	6.35%
3 months (2020-08-26)	-3.02%
6 months (2020-05-26)	52.56%

1 year (2019-11-26)	50.00%
2 years (2018-11-26)	53.44%
3 years (2017-11-24)	78.67%
5 years (2015-11-25)	538.10%

Is Avid Bioservices under- or over-valued?

Valuing Avid Bioservices stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Avid Bioservices's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Avid Bioservices's EBITDA

Avid Bioservices's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$702,000.

The EBITDA is a measure of a Avid Bioservices's overall financial performance and is widely used to measure a its profitability.

Avid Bioservices financials

Revenue TTM	USD$69.8 million
Gross profit TTM	USD$3.9 million
Return on assets TTM	-1.5%
Return on equity TTM	-5.35%
Profit margin	-3.68%
Book value	$0.822
Market capitalisation	USD$452.8 million

TTM: trailing 12 months

Shorting Avid Bioservices shares

There are currently 1.9 million Avid Bioservices shares held short by investors – that's known as Avid Bioservices's "short interest". This figure is 24.2% down from 2.6 million last month.

There are a few different ways that this level of interest in shorting Avid Bioservices shares can be evaluated.

Avid Bioservices's "short interest ratio" (SIR)

Avid Bioservices's "short interest ratio" (SIR) is the quantity of Avid Bioservices shares currently shorted divided by the average quantity of Avid Bioservices shares traded daily (recently around 478157.5308642). Avid Bioservices's SIR currently stands at 4.05. In other words for every 100,000 Avid Bioservices shares traded daily on the market, roughly 4050 shares are currently held short.

However Avid Bioservices's short interest can also be evaluated against the total number of Avid Bioservices shares, or, against the total number of tradable Avid Bioservices shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Avid Bioservices's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 Avid Bioservices shares in existence, roughly 30 shares are currently held short) or 0.0344% of the tradable shares (for every 100,000 tradable Avid Bioservices shares, roughly 34 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Avid Bioservices.

Find out more about how you can short Avid Bioservices stock.

Avid Bioservices share dividends

We're not expecting Avid Bioservices to pay a dividend over the next 12 months.

Have Avid Bioservices's shares ever split?

Avid Bioservices's shares were split on a 1:7 basis on 10 July 2017. So if you had owned 7 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Avid Bioservices shares – just the quantity. However, indirectly, the new 600% higher share price could have impacted the market appetite for Avid Bioservices shares which in turn could have impacted Avid Bioservices's share price.

Avid Bioservices share price volatility

Over the last 12 months, Avid Bioservices's shares have ranged in value from as little as $3.02 up to $9.1. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Avid Bioservices's is 2.262. This would suggest that Avid Bioservices's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Avid Bioservices overview

Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. It produces monoclonal antibodies and recombinant proteins; and offers services, including CGMP clinical and commercial drug substance manufacturing, purification, bulk packaging, release and stability testing, and regulatory submission and support. The company also provides various process development services, such as upstream and downstream development and optimization, analytical methods development, testing, and characterization. It serves biotechnology and pharmaceutical companies. Avid Bioservices, Inc. has a process development and manufacturing agreement with Oragenics, Inc. to develop coronavirus vaccine. The company was formerly known as Peregrine Pharmaceuticals, Inc. and changed its name to Avid Bioservices, Inc. in January 2018. Avid Bioservices, Inc. was founded in 1981 and is headquartered in Tustin, California.

Frequently asked questions

• What percentage of Avid Bioservices is owned by insiders or institutions?

  Currently 7.337% of Avid Bioservices shares are held by insiders and 58.056% by institutions.

• How many people work for Avid Bioservices?

  Latest data suggests 222 work at Avid Bioservices.

• When does the fiscal year end for Avid Bioservices?

  Avid Bioservices's fiscal year ends in April.

• Where is Avid Bioservices based?

  Avid Bioservices's address is: 2642 Michelle Drive, Tustin, CA, United States, 92780

• What is Avid Bioservices's CUSIP number?

  Avid Bioservices's Committee on Uniform Securities Identification Procedures number is: 05368M106